| BE0309-5MG
| InVivoMAb anti-mouse CXCL9 (MIG)
| 5 mg
| BioXCell
| in vivo CXCL9 neutralization, Immunofluorescence
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0323-50MG
| InVivoMAb anti-mouse TL1A (TNFSF15)
| 50 mg
| BioXCell
| in vivo TL1A neutralization, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0336-1MG
| InVivoMAb anti-human MUC1 (CD227)
| 1 mg
| BioXCell
| in vivo administration in mouse xenograft models,
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0300-5MG
| InVivoMAb anti-mouse CD45.2
| 5 mg
| BioXCell
| Flow cytometry, in vivo CD45.2 blockade, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0351-50MG
| InVivoMAb anti-human NKG2D (CD314)
| 50 mg
| BioXCell
| in vitro NKG2D blocking, Immunoprecipitation, Flow
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0366-100MG
| InVivoMAb mouse IgG2c isotype control, anti-dengue virus
| 100 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0371-1MG
| InVivoMAb anti-mouse IL-12 p35
| 1 mg
| BioXCell
| in vivo IL-12 p35 neutralization, in vitro IL-12 p
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0377-1MG
| InVivoMAb anti-mouse CD31 (PECAM-1)
| 1 mg
| BioXCell
| in vivo CD31 blocking, Intravital imaging, Immunof
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0339-1MG
| InVivoMAb anti-mouse NKG2AB6
| 1 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0351-100MG
| InVivoMAb anti-human NKG2D (CD314)
| 100 mg
| BioXCell
| in vitro NKG2D blocking, Immunoprecipitation, Flow
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0356-25MG
| InVivoMAb anti-mouse CD20
| 25 mg
| BioXCell
| in vivo B cell depletion, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0311-100MG
| InVivoMAb anti-mouse CD317 (BST2, PDCA-1)
| 100 mg
| BioXCell
| in vivo pDC depletion, Immunofluorescence, Flow cy
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0310-25MG
| InVivoMAb anti-mouse VISTA
| 25 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0358-100MG
| InVivoMAb anti-SARS-CoV-2 S protein (NTD)
| 100 mg
| BioXCell
| Flow cytometry, ELISA
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0314-100MG
| InVivoMAb anti-mouse TIM-1 (CD365)
| 100 mg
| BioXCell
| in vivo TIM-1 blockade, in vitro TIM-1 blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0363-5MG
| InVivoMAb anti-human CEACAM7
| 5 mg
| BioXCell
| Western blot*, ELISA*, Immunoprecipitation*, Immun
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0316-1MG
| InVivoMAb anti-mouse CCR3 (CD193)
| 1 mg
| BioXCell
| in vivo eosinophil depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0365-25MG
| InVivoMAb anti-mouse CD80 (B7-1)
| 25 mg
| BioXCell
| in vivo CD80 blockade, in vitro CD80 blockade, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0318-5MG
| InVivoMAb anti-human Ganglioside GD2
| 5 mg
| BioXCell
| in vitro induction of apoptosis in GD2+ cells, in
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0311-5MG
| InVivoMAb anti-mouse CD317 (BST2, PDCA-1)
| 5 mg
| BioXCell
| in vivo pDC depletion, Immunofluorescence, Flow cy
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0348-5MG
| InVivoMAb anti-mouse CD27
| 5 mg
| BioXCell
| in vivo CD27 stimulation, in vitro CD27 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0357-100MG
| InVivoMAb anti-SARS-CoV-2 S protein (RBD epitope A)
| 100 mg
| BioXCell
| in vitro blocking of SARS-CoV-2 S protein, Flow cy
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0335-50MG
| InVivoMAb anti-human MAGE-C2 (CT10)
| 50 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0323-5MG
| InVivoMAb anti-mouse TL1A (TNFSF15)
| 5 mg
| BioXCell
| in vivo TL1A neutralization, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0354-50MG
| InVivoMAb anti-human CD2
| 50 mg
| BioXCell
| in vivo CD2 blockade in huCD2tg mice
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0344-50MG
| InVivoMAb anti-mouse TIM-4
| 50 mg
| BioXCell
| Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0330-1MG
| InVivoMAb anti-mouse CD69
| 1 mg
| BioXCell
| in vivo down-regulation of CD69 expression, Functi
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0355-50MG
| InVivoMAb anti-human CA19-9
| 50 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0363-100MG
| InVivoMAb anti-human CEACAM7
| 100 mg
| BioXCell
| Western blot*, ELISA*, Immunoprecipitation*, Immun
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0348-50MG
| InVivoMAb anti-mouse CD27
| 50 mg
| BioXCell
| in vivo CD27 stimulation, in vitro CD27 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0365-1MG
| InVivoMAb anti-mouse CD80 (B7-1)
| 1 mg
| BioXCell
| in vivo CD80 blockade, in vitro CD80 blockade, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0340-5MG
| InVivoMAb anti-human/monkey MDR-1 (CD243)
| 5 mg
| BioXCell
| in vivo MDR-1 blocking/depletion in xenogeneic mur
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0334-5MG
| InVivoMAb anti-mouse NKG2D (CD314)
| 5 mg
| BioXCell
| in vivo NKG2D blockade, in vitro NKG2D blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|